MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)

NCT01154036 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1547

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: ezetimibe 10 mg
DRUG: atorvastatin
DRUG: Comparator: rosuvastatin

Sponsor

Organon and Co